Voyager Therapeutics (VYGR) Non-Current Deferred Revenue (2015 - 2025)
Voyager Therapeutics (VYGR) posted Non-Current Deffered Revenue of $1.47 million for Q3 2025, down 87.9% from $12.15 million a year earlier and down 43.6% from the prior quarter.
Powered by 
Analysis
Voyager Therapeutics (VYGR) Non-Current Deferred Revenue (2015 - 2025) Analysis & Trends
At the end of FY2024, Voyager Therapeutics' Non-Current Deffered Revenue came in at $6 million, down 81.4% from FY2023.
- Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of -47.3% (FY2019 to FY2024).
- In prior years, Voyager Therapeutics' Non-Current Deffered Revenue was $32.36 million in FY2023 (+401.7%), $6.45 million in FY2022 (-21.4%), $8.21 million in FY2021 (-77.3%) and $36.09 million in FY2020 (-75.5%).
- The Q3 2025 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to Q3 2015.
- On a year-over-year basis, Non-Current Deffered Revenue has declined in each of the last seven quarters, with an average decline of 16.4% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q1 2023, with growth of 833.5%; the weakest was Q3 2025, with a decline of 87.9%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $2.61 million (Q2 2025), $4.76 million (Q1 2025) and $6 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Voyager Therapeutics | 113.78 Mn | -447.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 2.61 Mn |
| Mar 31, 2025 | 4.76 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 12.15 Mn |
| Jun 30, 2024 | 19.47 Mn |
| Mar 31, 2024 | 13.16 Mn |
| Dec 31, 2023 | 32.36 Mn |
| Sep 30, 2023 | 37.83 Mn |
| Jun 30, 2023 | 51.38 Mn |
| Mar 31, 2023 | 78.87 Mn |
| Dec 31, 2022 | 6.45 Mn |
| Sep 30, 2022 | 7.39 Mn |
| Jun 30, 2022 | 7.88 Mn |
| Mar 31, 2022 | 8.45 Mn |
| Dec 31, 2021 | 8.21 Mn |
| Sep 30, 2021 | 29.64 Mn |
| Jun 30, 2021 | 31.66 Mn |
| Mar 31, 2021 | 33.61 Mn |
| Dec 31, 2020 | 36.09 Mn |
API Access
Voyager Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VYGR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VYGR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VYGR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();